In a collaboration meant to develop genomics-based protocols for precision medicine, Mayo Clinic is collaborating with Pittsburgh-based 2bPrecise, licensing its cloud-based platform to bring individualized clinical decision support to the point of care.
The platform combines clinical and genomic information, extracting patient-specific and presenting them to clinicians, within the EHR workflow, overlaying other sources of data help enable clinical genomics at point of care, said 2bPrecise officials.